Benzinga | Jan 27, 2022 07:14AM EST

Raymond James Maintains Outperform on Edwards Lifesciences, Lowers Price Target to $126

Raymond James analyst Jayson Bedford maintains Edwards Lifesciences (NYSE:EW) with a Outperform and lowers the price target from $134 to $126.